---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-115291"
form_type: "8-K"
ticker: "PACB"
cik: "0001299130"
company_name: "PACIFIC BIOSCIENCES OF CALIFORNIA, INC."
filed_at: "2024-11-07T23:59:59+00:00"
generated_at: "2026-05-30T03:20:47.512113+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# PacBio exchanges $459M 2028 notes for $200M 2029 notes, 20.5M shares, $50M cash

## Summary
- Exchanged $459M of 1.5% 2028 notes for $200M new 1.5% 2029 notes, 20.45M shares, and $50M cash.
- New notes mature Aug 2029, convertible at ~$4.89/share; interest paid semi-annually.
- All 2028 notes to be cancelled; none remain after close on/about Nov 21, 2024.
- Transaction extends debt maturity to 2029 and reduces principal by $259M but adds dilution.

## SEC filing metadata
- accession: 0001104659-24-115291
- form_type: 8-K
- ticker: PACB
- cik: 0001299130
- company_name: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- filed_at: 2024-11-07T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1299130/000110465924115291/0001104659-24-115291-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1299130/000110465924115291/tm2427787d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-115291
- JSON: https://secwatch.observer/filing/0001104659-24-115291.json
- Plain text: https://secwatch.observer/filing/0001104659-24-115291.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.